ICCC logo

ImmuCell Corporation (ICCC)

Profile

Full Name

ImmuCell Corporation

Ticker

NASDAQ: ICCC

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

May 5, 1987

Indexes

Not included

Website

https://immucell.com

Employees

67

Key Details

Price

$6.10(-9.23%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$26.49M(+51.63% YoY)

Annual EPS

-$0.26(+65.33% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $6.10
    ICCC price is $6.10

    30-Day Relative Volume

    2.31
    ICCC 30-day relative volume is 2.31

    Price Performance

    Price Most recent change

    -9.23%
    ICCC price was down -9.23% on Aug 15, 2025

    Price YTD change

    +18.45%
    ICCC price is up +18.45% since January 1st

    Price 1-year change

    +65.31%
    ICCC price is up +65.31% year-on-year

    Price 3-year change

    -24.32%
    ICCC price is down -24.32% over the past 3 years

    Price Range

    Price All-time high

    $21.88
    ICCC price is currently -72.11% below its historical high of $21.88

    Price 3-year low

    $3.34
    ICCC price is currently +82.63% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $55.13M
    ICCC market capitalization is $55.13 million

    Market cap 3-year change

    -11.71%
    ICCC market capitalization is down -11.71% over the past 3 years

    Market cap All-time high

    $85.76M
    ICCC market capitalization is currently -35.72% below its historical high of $85.76 million

    Market cap sector rank

    34.33%
    ICCC market capitalization is higher than 34.33% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +15.37%
    ICCC shares outstanding is up +15.37% year-on-year

    Shares Outstanding 3-Year Change

    +16.66%
    ICCC shares outstanding is up +16.66% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.25
    ICCC beta is 0.25

    200-day SMA

    $5.35
    ICCC price is currently +13.99% above its 200-day simple moving average

    50-day SMA

    $6.53
    ICCC price is currently -6.56% below its 50-day simple moving average

    RSI

    42.32
    ICCC 14-day relative strength index is 42.32

    Volume

    2.31
    ICCC 30-day relative volume is 2.31

    ATR

    $0.45
    ICCC average true range is $0.45

    10-day Historical Volatility

    72.31%
    ICCC 10-day historical volatility is 72.31%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $26.49M
    ICCC annual revenue is $26.49 million

    Revenue Analysts estimate

    -
    ICCC annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    +51.63%
    ICCC annual revenue is up +51.63% year-on-year

    Revenue Sector rank

    54.61%
    ICCC annual revenue is higher than 54.61% of companies in Healthcare sector

    EPS

    EPS

    -$0.26
    ICCC annual earnings per share is -$0.26

    EPS Analysts estimate

    -
    ICCC annual earnings per share consensus analysts' forecast is unknown

    EPS 1-year change

    +65.33%
    ICCC annual earnings per share is up +65.33% year-on-year

    EPS Sector rank

    69.63%
    ICCC annual earnings per share is higher than 69.63% of companies in Healthcare sector

    Profit

    Gross profit

    $7.94M
    ICCC annual gross profit is $7.94 million

    Gross margin

    29.97%
    ICCC annual gross profit margin is 29.97%

    Operating profit

    -$1.64M
    ICCC annual operating income is -$1.64 million

    Operating margin

    -6.19%
    ICCC annual operating profit margin is -6.19%

    Net income

    -$2.16M
    ICCC annual net profit is -$2.16 million

    Net margin

    -8.14%
    ICCC annual net profit margin is -8.14%

    Expenses

    Total expenses

    $28.13M
    ICCC annual total expenses is $28.13 million

    Operating expenses

    $9.58M
    ICCC annual total operating expenses is $9.58 million

    Cost of goods sold

    $18.55M
    ICCC annual cost of goods sold is $18.55 million

    Selling, general & administrative expenses

    $5.68M
    ICCC annual SGA is $5.68 million

    Depreciation and amortization

    $2.69M
    ICCC annual depreciation & amortization is $2.69 million

    Interest expense

    $0.00
    ICCC annual interest expense is $0.00

    Income tax

    $10.10K
    ICCC annual income tax is $10.10 thousand

    EBIT & EBITDA

    EBIT

    -$1.64M
    ICCC annual earnings before interest & taxes is -$1.64 million

    EBITDA

    -$1.64M
    ICCC annual EBITDA is -$1.64 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $45.10M
    ICCC annual total assets is $45.10 million

    Non current assets

    $30.06M
    ICCC annual long term assets is $30.06 million

    Current assets

    $3.76M
    ICCC annual total current assets is $3.76 million

    Cash and cash equivalents

    $3.76M
    ICCC annual cash & cash equivalents is $3.76 million

    Accounts receivable

    $3.77M
    ICCC annual accounts receivable is $3.77 million

    Inventory

    $7.11M
    ICCC annual inventory is $7.11 million

    Liabilities

    Total liabilities

    $17.58M
    ICCC annual total liabilities is $17.58 million

    Long term liabilities

    $13.17M
    ICCC annual total long term liabilities is $13.17 million

    Current liabilities

    $4.41M
    ICCC annual total current liabilities is $4.41 million

    Accounts payable

    $943.60K
    ICCC annual accounts payable is $943.60 thousand

    Debt

    Total debt

    $15.10M
    ICCC annual total debt is $15.10 million

    Total debt 1-year change

    -9.53%
    ICCC annual total debt is down -9.53% year-on-year

    Long term debt

    $13.17M
    ICCC annual long term debt is $13.17 million

    Short term debt

    $1.93M
    ICCC annual short term debt is $1.93 million

    Equity & Capital

    Shareholders equity

    $27.52M
    ICCC annual stockholders equity is $27.52 million

    Book value

    $27.52M
    ICCC annual book value is $27.52 million

    Retained earnings

    -$14.16M
    ICCC annual retained earnings is -$14.16 million

    Working capital

    $10.63M
    ICCC annual working capital is $10.63 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $357.90K
    ICCC annual cash flow from operations is $357.90 thousand

    Cash from operations 1-year change

    +107.66%
    ICCC annual cash flow from operations is up +107.66% year-on-year

    Cash from investing

    -$461.20K
    ICCC annual cash flow from investing activities is -$461.20 thousand

    Cash from investing 1-year change

    +75.6%
    ICCC annual cash flow from investing activities is up +75.6% year-on-year

    Cash from financing

    $2.88M
    ICCC annual cash flow from financing activities is $2.88 million

    Cash from financing 1-year change

    +64.59%
    ICCC annual cash flow from financing activities is up +64.59% year-on-year

    CAPEX

    CAPEX

    $465.70K
    ICCC annual capital expenditures is $465.70 thousand

    CAPEX 1-year change

    -75.39%
    ICCC annual capital expenditures is down -75.39% year-on-year

    Free Cash Flow

    Free cash flow

    -$107.80K
    ICCC annual free cash flow is -$107.80 thousand

    Free cash flow 1-year change

    +98.36%
    ICCC annual free cash flow is up +98.36% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    29.97%
    ICCC annual gross profit margin is 29.97%

    Operating margin

    -6.19%
    ICCC annual operating profit margin is -6.19%

    Net margin

    -8.14%
    ICCC annual net profit margin is -8.14%

    ROA & ROE

    ROA

    -4.85%
    ICCC annual return on assets is -4.85%

    ROE

    -8.21%
    ICCC annual return on equity is -8.21%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    ICCC price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    ICCC price to earnings ratio is unknown

    PB Ratio

    PB ratio

    1.90
    ICCC price to book ratio is 1.90

    PB ratio Sector rank

    52.92%
    ICCC price to book ratio is higher than 52.92% of companies in Healthcare sector

    PS Ratio

    PS ratio

    2.02
    ICCC price to sales ratio is 2.02

    PS ratio Sector rank

    37%
    ICCC price to sales ratio is higher than 37% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $65.19M
    ICCC enterprise value is $65.19 million

    Enterprise value Sector rank

    37.75%
    ICCC enterprise value is higher than 37.75% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    22.08
    ICCC EV/EBITDA is 22.08

    EV/EBITDA Sector rank

    92.05%
    ICCC EV/EBITDA is higher than 92.05% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    3.41
    ICCC annual current ratio is 3.41

    Quick ratio

    -
    ICCC annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.00
    ICCC annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    ICCC annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    ICCC piotroski f-score value is unknown

    Altman Z-Score

    2.19
    ICCC altman z-score is 2.19

    Analyst ratings

    Recent major analysts updates

    Jul 13, 20 Aegis Capital
    Buy

    Institutional Ownership

    Screeners with ICCC included

    Growing Shares Outstanding
    US stocks
    High Piotroski score stocks
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for ImmuCell Corporation?
    • Does ImmuCell Corporation pay dividends?
    • What sector is ImmuCell Corporation in?
    • What industry is ImmuCell Corporation in?
    • What country is ImmuCell Corporation based in?
    • When did ImmuCell Corporation go public?
    • Is ImmuCell Corporation in the S&P 500?
    • Is ImmuCell Corporation in the NASDAQ 100?
    • Is ImmuCell Corporation in the Dow Jones?
    • When was ImmuCell Corporation's last earnings report?
    • When does ImmuCell Corporation report earnings?

    What is the ticker symbol for ImmuCell Corporation?

    The ticker symbol for ImmuCell Corporation is NASDAQ:ICCC

    Does ImmuCell Corporation pay dividends?

    No, ImmuCell Corporation does not pay dividends

    What sector is ImmuCell Corporation in?

    ImmuCell Corporation is in the Healthcare sector

    What industry is ImmuCell Corporation in?

    ImmuCell Corporation is in the Biotechnology industry

    What country is ImmuCell Corporation based in?

    ImmuCell Corporation is headquartered in United States

    When did ImmuCell Corporation go public?

    ImmuCell Corporation's initial public offering (IPO) was on May 5, 1987

    Is ImmuCell Corporation in the S&P 500?

    No, ImmuCell Corporation is not included in the S&P 500 index

    Is ImmuCell Corporation in the NASDAQ 100?

    No, ImmuCell Corporation is not included in the NASDAQ 100 index

    Is ImmuCell Corporation in the Dow Jones?

    No, ImmuCell Corporation is not included in the Dow Jones index

    When was ImmuCell Corporation's last earnings report?

    ImmuCell Corporation's most recent earnings report was on August 14, 2025

    When does ImmuCell Corporation report earnings?

    The date for ImmuCell Corporation's next earnings report has not been announced yet
    On this page